New device offers hope for liver cancer patients out of options

NCT ID NCT07118202

First seen Nov 06, 2025 · Last updated Jun 17, 2026 · Updated 25 times

Summary

This study tests a device called TheraBionic P1 in people with advanced liver cancer who have already tried at least two other treatments or cannot take standard therapy. The goal is to see if the device can help them live longer and improve their quality of life. About 198 adults will use the device at home, and researchers will track survival, side effects, and how the cancer responds.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA RECURRENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Karmanos Cancer Institute

    RECRUITING

    Detroit, Michigan, 48201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Karmanos Cancer Institute at McLaren Bay Region

    RECRUITING

    Bay City, Michigan, 48706, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Central Michigan, Morey Cancer Center

    RECRUITING

    Mount Pleasant, Michigan, 48858, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Flint

    RECRUITING

    Flint, Michigan, 48532, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Greater Lansing

    RECRUITING

    Lansing, Michigan, 48910, United States

    Contact Phone: •••-•••-••••

  • Karmanos Cancer Institute at McLaren Lapeer Region

    RECRUITING

    Lapeer, Michigan, 48446, United States

    Contact Phone: •••-•••-••••

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.